Anterior Cruciate Ligament Pain Study



Status:Recruiting
Healthy:No
Age Range:Any
Updated:4/21/2016
Start Date:November 2015
End Date:May 2016
Contact:Ericka Brewer
Email:ericka.brewer@emory.edu
Phone:404-778-6857

Use our guide to learn which trials are right for you!

Comparison Between Femoral Nerve Block and Adductor Canal Block for Anterior Cruciate Ligament Reconstruction: A Prospective Randomized Controlled Trial

The objective of this study is to compare the pain control benefit of two different types of
nerve blocks in patients undergoing anterior cruciate ligament (ACL) reconstruction.

This trial is a prospective, randomized, surgeon-blinded, two-armed trial to investigate the
safety and efficacy of femoral nerve blocks versus adductor canal blocks versus no block for
participants undergoing outpatient anterior cruciate ligament (ACL) reconstruction surgery.

The objective of this study is to compare the pain control benefit of two different types of
nerve blocks. Ropivacaine, which is FDA-approved for use in both femoral nerve blocks as
well as adductor canal blocks, will be utilized. The study will be comparing the efficacy
between FDA approved treatments.

Inclusion Criteria:

- Patients undergoing scheduled anterior cruciate ligament (ACL) surgery at the Emory
Orthopaedic and Spine Center

- Patients willing and able to provide written informed consent

- Parents willing and able to provide written informed consent for minors

Exclusion Criteria:

- Patients who are pregnant or lactating

- Patients with liver dysfunction or renal failure

- Patients with a known allergy to ropivacaine

- Patients with a local infection

- Patients who take chronic pain medications

- Patients with an opioid tolerance

- Patients with known coagulopathy or bleeding risk.

- Patients who are getting neuraxial anesthesia for surgery
We found this trial at
1
site
Atlanta, Georgia 30329
Principal Investigator: John Xerogeanes, MD
Phone: 404-778-6857
?
mi
from
Atlanta, GA
Click here to add this to my saved trials